cefuroxime has been researched along with Prostatic Hyperplasia in 1 studies
Cefuroxime: Broad-spectrum cephalosporin antibiotic resistant to beta-lactamase. It has been proposed for infections with gram-negative and gram-positive organisms, GONORRHEA, and HAEMOPHILUS.
cefuroxime : A 3-(carbamoyloxymethyl)cephalosporin compound having a 7-(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetamido side chain.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Excerpt | Relevance | Reference |
---|---|---|
"From 33 patients with prostatic adenoma with an average age of 68." | 1.26 | [Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)]. ( Adam, D; Boettger, F; Schalkhäuser, K, 1979) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adam, D | 1 |
Schalkhäuser, K | 1 |
Boettger, F | 1 |
1 other study available for cefuroxime and Prostatic Hyperplasia
Article | Year |
---|---|
[Diffusion of cefuroxime into the prostatic and other tissues of the urogenital region (author's transl)].
Topics: Adult; Aged; Cefuroxime; Cephalosporins; Electrosurgery; Humans; Male; Middle Aged; Prostate; Prosta | 1979 |